Pepsin-digested peanut contains T-cell epitopes but no IgE epitopes

Area of Science:

• Food allergy research
• Immunology
• Allergen modification

Background:

• Peanut allergy is a leading cause of anaphylaxis.
• Current rush immunotherapy with crude peanut extract has high rates of allergic reactions.
• Modifying peanut antigens to reduce allergenicity is a potential strategy.

Purpose of the Study:

• To investigate the immunologic properties of peanut extract before and after pepsin digestion.
• To assess changes in IgE reactivity and T-cell responses.

Main Methods:

• IgE immunoblotting was used to detect IgE-binding proteins.
• T-lymphocyte proliferation assays were performed on peripheral blood mononuclear cells (PBMCs).
• Interferon-gamma (IFN-gamma) production was measured.

Main Results:

• Pepsin digestion eliminated multiple IgE-reactive proteins in peanut extract.
• Pepsin-digested peanut induced significant T-cell proliferation and IFN-gamma production in subjects with peanut allergy.
• T-cell lines generated against intact peanut also recognized pepsin-digested peanut, indicating conserved T-cell epitopes.

Conclusions:

• Pepsin digestion of peanut extract reduces IgE reactivity, a key factor in allergic reactions.
• The T-cell response is maintained after pepsin digestion, suggesting preserved immunogenicity.
• Pepsin-digested peanut holds promise as a safer alternative for peanut immunotherapy.